Stereotactic Radiotherapy Plus Temozolomide for Refractory Brain Metastases

Clinical trial NCT02654106 · COMPLETED

Trial details

NCT number: NCT02654106
Sponsor: Chinese Academy of Medical Sciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain Metastases

Start date: 2011-10-01
Primary completion: 2015-11-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.